Overview
Cardiovascular Disease Risk in Women With Endometriosis
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2025-08-30
2025-08-30
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
To test the hypothesis that estrogen suppression impairs endothelial dysfunction in endometriosis.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Yale UniversityTreatments:
Ganirelix
Criteria
Inclusion Criteria:- Young women between the ages of 18 and 45 years (Controls);
- Young women between the ages of 18 and 45 years with endometriosis.
Exclusion Criteria:
- Subjects who smoke
- Subjects who have diabetes,
- Subjects with sleep apnea or BP>140/90 will be excluded.
- Women with endometriosis and severe acute pain requiring immediate treatment will be
excluded.